Skip to main content
Erschienen in: Pediatric Nephrology 4/2019

18.04.2018 | Educational Review

Vaccinations in pediatric kidney transplant recipients

Erschienen in: Pediatric Nephrology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Pediatric kidney transplant (KT) candidates should be fully immunized according to routine childhood schedules using age-appropriate guidelines. Unfortunately, vaccination rates in KT candidates remain suboptimal. With the exception of influenza vaccine, vaccination after transplantation should be delayed 3–6 months to maximize immunogenicity. While most vaccinations in the KT recipient are administered by primary care physicians, there are specific schedule alterations in the cases of influenza, hepatitis B, pneumococcal, and meningococcal vaccinations; consequently, these vaccines are usually administered by transplant physicians. This article will focus on those deviations from the normal vaccine schedule important in the care of pediatric KT recipients. The article will also review human papillomavirus vaccine due to its special importance in cancer prevention. Live vaccines are generally contraindicated in KT recipients. However, we present a brief review of live vaccines in organ transplant recipients, as there is evidence that certain live virus vaccines may be safe and effective in select groups. Lastly, we review vaccination of pediatric KT recipients prior to international travel.
Literatur
1.
Zurück zum Zitat Ventola CL (2016) Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 1: childhood vaccinations. P T 41:426–436PubMedPubMedCentral Ventola CL (2016) Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 1: childhood vaccinations. P T 41:426–436PubMedPubMedCentral
2.
Zurück zum Zitat Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Dietz V (2016) Vaccination coverage among children aged 19-35 months—United States, 2015. MMWR Morb Mortal Wkly Rep 65:1065–1071CrossRefPubMed Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Dietz V (2016) Vaccination coverage among children aged 19-35 months—United States, 2015. MMWR Morb Mortal Wkly Rep 65:1065–1071CrossRefPubMed
3.
Zurück zum Zitat Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 66:874–882CrossRefPubMedPubMedCentral Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 66:874–882CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS (2015) Measles—United States, January 4-April 2, 2015. MMWR Morb Mortal Wkly Rep 64:373–376PubMedPubMedCentral Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS (2015) Measles—United States, January 4-April 2, 2015. MMWR Morb Mortal Wkly Rep 64:373–376PubMedPubMedCentral
5.
Zurück zum Zitat Kotton CN, Hibberd PL (2013) Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant 13(Suppl 4):337–347CrossRefPubMed Kotton CN, Hibberd PL (2013) Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant 13(Suppl 4):337–347CrossRefPubMed
6.
Zurück zum Zitat Rubin L, Levin M, Ljungman P, Davies E, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58:309–318CrossRefPubMed Rubin L, Levin M, Ljungman P, Davies E, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58:309–318CrossRefPubMed
8.
Zurück zum Zitat Esposito S, Mastrolia M, Prada E, Pietrasanta C, Principi N (2014) Vaccine administration in children with chronic kidney disease. Vaccine 32:6601–6606CrossRefPubMed Esposito S, Mastrolia M, Prada E, Pietrasanta C, Principi N (2014) Vaccine administration in children with chronic kidney disease. Vaccine 32:6601–6606CrossRefPubMed
9.
Zurück zum Zitat Gangappa S, Kokko K, Carlson L, Gourley T, Newell K, Pearson T, Ahmed R, Larsen C (2008) Immune responsiveness and protective immunity after transplantation. Transpl Int 21:293–303CrossRefPubMed Gangappa S, Kokko K, Carlson L, Gourley T, Newell K, Pearson T, Ahmed R, Larsen C (2008) Immune responsiveness and protective immunity after transplantation. Transpl Int 21:293–303CrossRefPubMed
10.
Zurück zum Zitat Abuali M, Arnon R, Posada R (2011) An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant 15:770–777CrossRefPubMed Abuali M, Arnon R, Posada R (2011) An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant 15:770–777CrossRefPubMed
11.
Zurück zum Zitat Cheng DR, Barton R, Greenway A, Crawford NW (2016) Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines 15:1567–1574CrossRefPubMed Cheng DR, Barton R, Greenway A, Crawford NW (2016) Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines 15:1567–1574CrossRefPubMed
12.
Zurück zum Zitat American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, p 80 American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, p 80
13.
Zurück zum Zitat American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, p 83 American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, p 83
14.
Zurück zum Zitat Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, Masson P, De Keyser F (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 49:1815–1827CrossRef Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, Masson P, De Keyser F (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 49:1815–1827CrossRef
15.
Zurück zum Zitat American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, pp 38-40 American Academy of Pediatrics. Committee on Infectious Diseases (2015) Red book: report of the Committee on Infectious Diseases, 30th edn. American Academy of Pediatrics, Elk Grove Village, IL, pp 38-40
16.
Zurück zum Zitat Ladd J, Karkazis K, Magnus D (2013) Parental refusal of vaccination and transplantation listing decisions: a nationwide survey. Pediatr Transplant 17:244–250CrossRefPubMed Ladd J, Karkazis K, Magnus D (2013) Parental refusal of vaccination and transplantation listing decisions: a nationwide survey. Pediatr Transplant 17:244–250CrossRefPubMed
17.
Zurück zum Zitat Benden C, Danziger-Isakov L, Astor T, Aurora P, Bluemchen K, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Michaels M, Mogayzel P, Mueller C, Parakininkas D, Oberkfell D, Solomon M, Boehler A (2007) Variability in immunization guidelines in children before and after lung transplantation. Pediatr Transplant 11:882–887CrossRefPubMed Benden C, Danziger-Isakov L, Astor T, Aurora P, Bluemchen K, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Michaels M, Mogayzel P, Mueller C, Parakininkas D, Oberkfell D, Solomon M, Boehler A (2007) Variability in immunization guidelines in children before and after lung transplantation. Pediatr Transplant 11:882–887CrossRefPubMed
18.
Zurück zum Zitat Lee D, Boyle S, Malat G, Sharma A, Bias T, Doyle A (2016) Low rates of vaccination in listed kidney transplant candidates. Transpl Infect Dis 18:155–159CrossRefPubMed Lee D, Boyle S, Malat G, Sharma A, Bias T, Doyle A (2016) Low rates of vaccination in listed kidney transplant candidates. Transpl Infect Dis 18:155–159CrossRefPubMed
19.
Zurück zum Zitat Chon W, Kadambi P, Harland R, Thistlethwaite J, West B, Udani S, Poduval R, Josephson M (2010) Changing attitudes toward influenza vaccination in U.S. kidney transplant programs over the past decade. Clin J Am Soc Nephrol 5:1637–1641CrossRefPubMedPubMedCentral Chon W, Kadambi P, Harland R, Thistlethwaite J, West B, Udani S, Poduval R, Josephson M (2010) Changing attitudes toward influenza vaccination in U.S. kidney transplant programs over the past decade. Clin J Am Soc Nephrol 5:1637–1641CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Smith J, Metzger N (2011) Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital. J Manag Care Pharm 17:701–708PubMed Smith J, Metzger N (2011) Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital. J Manag Care Pharm 17:701–708PubMed
21.
Zurück zum Zitat KDIGO (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1–S155 KDIGO (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1–S155
22.
Zurück zum Zitat Struijk G, Lammers A, Brinkman R, Lombarts M, van VM, van dPK, Ten BI, Bemelman F (2015) Immunization after renal transplantation: current clinical practice. Transpl Infect Dis 17:192–200CrossRefPubMed Struijk G, Lammers A, Brinkman R, Lombarts M, van VM, van dPK, Ten BI, Bemelman F (2015) Immunization after renal transplantation: current clinical practice. Transpl Infect Dis 17:192–200CrossRefPubMed
23.
Zurück zum Zitat Chesi C, Gunther M, Huzly D, Neuhaus R, Reinke P, Engelmann HB, Mockenhaupt FP, Bienzle U (2009) Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey. Transpl Infect Dis 11:507–512CrossRefPubMed Chesi C, Gunther M, Huzly D, Neuhaus R, Reinke P, Engelmann HB, Mockenhaupt FP, Bienzle U (2009) Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey. Transpl Infect Dis 11:507–512CrossRefPubMed
24.
Zurück zum Zitat Vilchez R, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S (2002) Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2:287–291CrossRefPubMed Vilchez R, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S (2002) Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2:287–291CrossRefPubMed
25.
Zurück zum Zitat Dos SG, Haguinet F, Cohet C, Webb D, Logie J, Ferreira G, Rosillon D, Shinde V (2016) Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: a self-controlled case-series. Vaccine 20:30299–30297 Dos SG, Haguinet F, Cohet C, Webb D, Logie J, Ferreira G, Rosillon D, Shinde V (2016) Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: a self-controlled case-series. Vaccine 20:30299–30297
26.
Zurück zum Zitat Robinson CL, Romero JR, Kempe A, Pellegrini C (2017) Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger—United States, 2017. Am J Transplant 17:1136–1138CrossRefPubMed Robinson CL, Romero JR, Kempe A, Pellegrini C (2017) Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger—United States, 2017. Am J Transplant 17:1136–1138CrossRefPubMed
27.
Zurück zum Zitat Furth S, Neu A, McColley S, Case B, Steinhoff M, Fivush B (1995) Immune response to influenza vaccination in children with renal disease. Pediatr Nephrol 9:566–568CrossRefPubMed Furth S, Neu A, McColley S, Case B, Steinhoff M, Fivush B (1995) Immune response to influenza vaccination in children with renal disease. Pediatr Nephrol 9:566–568CrossRefPubMed
28.
Zurück zum Zitat Mauch T, Crouch N, Freese D, Braunlin E, Dunn D, Kashtan C (1995) Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 127:957–960CrossRefPubMed Mauch T, Crouch N, Freese D, Braunlin E, Dunn D, Kashtan C (1995) Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 127:957–960CrossRefPubMed
29.
Zurück zum Zitat Nailescu C, Xu X, Zhou H, Hall H, Wilson A, Leiser J, Chand D, Valentini R, Hebert D, Mahan J (2011) Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 26:459–467CrossRefPubMed Nailescu C, Xu X, Zhou H, Hall H, Wilson A, Leiser J, Chand D, Valentini R, Hebert D, Mahan J (2011) Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 26:459–467CrossRefPubMed
30.
Zurück zum Zitat Salles M, Sens Y, Boas L, Machado C (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transpl 24:E17–E23CrossRef Salles M, Sens Y, Boas L, Machado C (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transpl 24:E17–E23CrossRef
31.
Zurück zum Zitat Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavalda J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Munoz P, Sabe N, Farinas MC, Blanes-Julia M, Lopez-Medrano F, Suarez-Benjumea A, Martinez-Atienza J, Rosso-Fernandez C, Perez-Romero P (2017) Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis 64:829–838CrossRefPubMed Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavalda J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Munoz P, Sabe N, Farinas MC, Blanes-Julia M, Lopez-Medrano F, Suarez-Benjumea A, Martinez-Atienza J, Rosso-Fernandez C, Perez-Romero P (2017) Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis 64:829–838CrossRefPubMed
32.
Zurück zum Zitat Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavalda J, Aydillo T, Moreno A, Montejo M, Farinas M, Carratala J, Munoz P, Blanes M, Fortun J, Suarez-Benjumea A, Lopez-Medrano F, Barranco J, Peghin M, Roca C, Lara R, Cordero E (2015) Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe. Clin Microbiol Infect 21:1040.e1011–1040.e1048CrossRef Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavalda J, Aydillo T, Moreno A, Montejo M, Farinas M, Carratala J, Munoz P, Blanes M, Fortun J, Suarez-Benjumea A, Lopez-Medrano F, Barranco J, Peghin M, Roca C, Lara R, Cordero E (2015) Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe. Clin Microbiol Infect 21:1040.e1011–1040.e1048CrossRef
33.
Zurück zum Zitat Friedrich P, Sattler A, Muller K, Nienen M, Reinke P, Babel N (2015) Comparing humoral and cellular immune response against HBV vaccine in kidney transplant patients. Am J Transplant 15:3157–3165CrossRefPubMed Friedrich P, Sattler A, Muller K, Nienen M, Reinke P, Babel N (2015) Comparing humoral and cellular immune response against HBV vaccine in kidney transplant patients. Am J Transplant 15:3157–3165CrossRefPubMed
34.
Zurück zum Zitat Watkins S, Alexander S, Brewer E, Hesley T, West D, Chan I, Mendelman P, Bailey S, Burns J, Hogg R (2002) Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 40:365–372CrossRefPubMed Watkins S, Alexander S, Brewer E, Hesley T, West D, Chan I, Mendelman P, Bailey S, Burns J, Hogg R (2002) Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 40:365–372CrossRefPubMed
35.
Zurück zum Zitat Moal V, Motte A, Vacher-Coponat H, Tamalet C, Berland Y, Colson P (2015) Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation. J Clin Virol 68:32–36CrossRefPubMed Moal V, Motte A, Vacher-Coponat H, Tamalet C, Berland Y, Colson P (2015) Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation. J Clin Virol 68:32–36CrossRefPubMed
36.
Zurück zum Zitat (2000) Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 355:561–565 (2000) Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 355:561–565
37.
Zurück zum Zitat Leonardi S, Pratico A, Lionetti E, Spina M, Vitaliti G, La RM (2012) Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 18:5729–5733CrossRefPubMedPubMedCentral Leonardi S, Pratico A, Lionetti E, Spina M, Vitaliti G, La RM (2012) Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 18:5729–5733CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Shouval D, Roggendorf H, Roggendorf M (2015) Enhanced immune response to hepatitis B vaccination through immunization with a pre-S1/pre-S2/S vaccine. Med Microbiol Immunol 204:57–68CrossRefPubMedPubMedCentral Shouval D, Roggendorf H, Roggendorf M (2015) Enhanced immune response to hepatitis B vaccination through immunization with a pre-S1/pre-S2/S vaccine. Med Microbiol Immunol 204:57–68CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Kanaan N, Kabamba B, Marechal C, Pirson Y, Beguin C, Goffin E, Hassoun Z (2012) Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. J Clin Virol 55:233–238CrossRefPubMed Kanaan N, Kabamba B, Marechal C, Pirson Y, Beguin C, Goffin E, Hassoun Z (2012) Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. J Clin Virol 55:233–238CrossRefPubMed
40.
Zurück zum Zitat Nuorti J, Whitney C (2010) Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18PubMed Nuorti J, Whitney C (2010) Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18PubMed
41.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2013) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 62:521–524 Centers for Disease Control and Prevention (CDC) (2013) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 62:521–524
42.
Zurück zum Zitat Tran L, Hebert D, Dipchand A, Fecteau A, Richardson S, Allen U (2005) Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant 9:183–186CrossRefPubMed Tran L, Hebert D, Dipchand A, Fecteau A, Richardson S, Allen U (2005) Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant 9:183–186CrossRefPubMed
43.
Zurück zum Zitat Barton M, Wasfy S, Dipchand A, Hebert D, Ng V, Solomon M, Fecteau A, Stephen D, Allen U (2009) Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J 28:688–692CrossRefPubMed Barton M, Wasfy S, Dipchand A, Hebert D, Ng V, Solomon M, Fecteau A, Stephen D, Allen U (2009) Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J 28:688–692CrossRefPubMed
44.
Zurück zum Zitat Lindemann M, Heinemann F, Horn P, Witzke O (2010) Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation 90:1463–1467CrossRefPubMed Lindemann M, Heinemann F, Horn P, Witzke O (2010) Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation 90:1463–1467CrossRefPubMed
45.
Zurück zum Zitat Broeders E, Wissing K, Ghisdal L, Lemy A, Hoang A, Vereerstraeten P, Mascart F, Abramowicz D (2013) Large decrease of anti-tetanus anatoxin and anti-pneumococcal antibodies at one year after renal transplantation. Clin Nephrol 79:313–317CrossRefPubMed Broeders E, Wissing K, Ghisdal L, Lemy A, Hoang A, Vereerstraeten P, Mascart F, Abramowicz D (2013) Large decrease of anti-tetanus anatoxin and anti-pneumococcal antibodies at one year after renal transplantation. Clin Nephrol 79:313–317CrossRefPubMed
46.
Zurück zum Zitat Lindemann M, Heinemann F, Horn P, Witzke O (2012) Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation 94:50–56CrossRefPubMed Lindemann M, Heinemann F, Horn P, Witzke O (2012) Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation 94:50–56CrossRefPubMed
47.
Zurück zum Zitat Kumar D, Welsh B, Siegal D, Chen M, Humar A (2007) Immunogenicity of pneumococcal vaccine in renal transplant recipients—three year follow-up of a randomized trial. Am J Transplant 7:633–638CrossRefPubMed Kumar D, Welsh B, Siegal D, Chen M, Humar A (2007) Immunogenicity of pneumococcal vaccine in renal transplant recipients—three year follow-up of a randomized trial. Am J Transplant 7:633–638CrossRefPubMed
48.
Zurück zum Zitat Malone K, Clark S, Palmer J, Lopez S, Pradhan M, Furth S, Kim J, Fisher B, Laskin B (2016) A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant. Pediatr Transplant 22:12742 Malone K, Clark S, Palmer J, Lopez S, Pradhan M, Furth S, Kim J, Fisher B, Laskin B (2016) A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant. Pediatr Transplant 22:12742
49.
Zurück zum Zitat Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE (2013) Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62:1–28PubMed Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE (2013) Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62:1–28PubMed
51.
Zurück zum Zitat Wyplosz B, Derradji O, Hong E, Francois H, Durrbach A, Duclos-Vallee JC, Samuel D, Escaut L, Launay O, Vittecoq D, Taha MK (2015) Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Transpl Infect Dis 17:322–327CrossRefPubMed Wyplosz B, Derradji O, Hong E, Francois H, Durrbach A, Duclos-Vallee JC, Samuel D, Escaut L, Launay O, Vittecoq D, Taha MK (2015) Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Transpl Infect Dis 17:322–327CrossRefPubMed
52.
Zurück zum Zitat Zlamy M, Elias J, Vogel U, Frosch M, Jeller V, Cortina G, Jungraithmayr T, Prelog M (2011) Immunogenicity of conjugate meningococcus C vaccine in pediatric solid organ transplant recipients. Vaccine 29:6163–6166CrossRefPubMed Zlamy M, Elias J, Vogel U, Frosch M, Jeller V, Cortina G, Jungraithmayr T, Prelog M (2011) Immunogenicity of conjugate meningococcus C vaccine in pediatric solid organ transplant recipients. Vaccine 29:6163–6166CrossRefPubMed
53.
Zurück zum Zitat Committee on Infectious Diseases (2011) Meningococcal conjugate vaccines policy update: booster dose recommendations. Pediatrics 128:1213–1218CrossRef Committee on Infectious Diseases (2011) Meningococcal conjugate vaccines policy update: booster dose recommendations. Pediatrics 128:1213–1218CrossRef
54.
Zurück zum Zitat Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR (2015) Use of serogroup B meningococcal vaccines in persons aged >/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 64:608–612PubMedPubMedCentral Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR (2015) Use of serogroup B meningococcal vaccines in persons aged >/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 64:608–612PubMedPubMedCentral
55.
Zurück zum Zitat Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M (2012) Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Pediatr Transplant 16:E246–E250CrossRefPubMed Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M (2012) Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Pediatr Transplant 16:E246–E250CrossRefPubMed
56.
Zurück zum Zitat Hinten F, Meeuwis K, van RM, de HJ (2012) HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients. Crit Rev Oncol Hematol 84:161–180CrossRefPubMed Hinten F, Meeuwis K, van RM, de HJ (2012) HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients. Crit Rev Oncol Hematol 84:161–180CrossRefPubMed
57.
Zurück zum Zitat de SS, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B, Tous S, Felix A, Bravo L, Shin H, Vallejos C, de RP, Lima M, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti S, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez G, Lombardi L, Banjo A, Menendez C, Domingo E, Velasco J, Nessa A, Chichareon S, Qiao Y, Lerma E, Garland S, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer C, Al-Jassar W, Cruz E, Wright T, Puras A, Llave C, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez G, Nowakowski A, Bornstein J, Munoz N, Bosch F (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056CrossRef de SS, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B, Tous S, Felix A, Bravo L, Shin H, Vallejos C, de RP, Lima M, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti S, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez G, Lombardi L, Banjo A, Menendez C, Domingo E, Velasco J, Nessa A, Chichareon S, Qiao Y, Lerma E, Garland S, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer C, Al-Jassar W, Cruz E, Wright T, Puras A, Llave C, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez G, Nowakowski A, Bornstein J, Munoz N, Bosch F (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056CrossRef
58.
Zurück zum Zitat Brown D, Garland S, Ferris D, Joura E, Steben M, James M, Radley D, Vuocolo S, Garner E, Haupt R, Bryan J (2011) The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Hum Vaccin 7:230–238CrossRefPubMed Brown D, Garland S, Ferris D, Joura E, Steben M, James M, Radley D, Vuocolo S, Garner E, Haupt R, Bryan J (2011) The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Hum Vaccin 7:230–238CrossRefPubMed
59.
Zurück zum Zitat Kumar D, Unger E, Panicker G, Medvedev P, Wilson L, Humar A (2013) Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 13:2411–2417CrossRefPubMedPubMedCentral Kumar D, Unger E, Panicker G, Medvedev P, Wilson L, Humar A (2013) Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 13:2411–2417CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Gomez-Lobo V, Whyte T, Kaufman S, Torres C, Moudgil A (2014) Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients. Pediatr Transplant 18:310–315CrossRefPubMed Gomez-Lobo V, Whyte T, Kaufman S, Torres C, Moudgil A (2014) Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients. Pediatr Transplant 18:310–315CrossRefPubMed
61.
Zurück zum Zitat Nelson D, Neu A, Abraham A, Amaral S, Batisky D, Fadrowski J (2016) Immunogenicity of human papillomavirus recombinant vaccine in children with CKD. Clin J Am Soc Nephrol 11:776–784CrossRefPubMedPubMedCentral Nelson D, Neu A, Abraham A, Amaral S, Batisky D, Fadrowski J (2016) Immunogenicity of human papillomavirus recombinant vaccine in children with CKD. Clin J Am Soc Nephrol 11:776–784CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Chong PP, Avery RK (2017) A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients. Clin Ther 39:1581–1598CrossRefPubMed Chong PP, Avery RK (2017) A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients. Clin Ther 39:1581–1598CrossRefPubMed
63.
Zurück zum Zitat Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C (1997) Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 99:35–39CrossRefPubMed Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C (1997) Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 99:35–39CrossRefPubMed
64.
Zurück zum Zitat Kano H, Mizuta K, Sakakihara Y, Kato H, Miki Y, Shibuya N, Saito M, Narita M, Kawarasaki H, Igarashi T, Hashizume K, Iwata T (2002) Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation 74:543–550CrossRefPubMed Kano H, Mizuta K, Sakakihara Y, Kato H, Miki Y, Shibuya N, Saito M, Narita M, Kawarasaki H, Igarashi T, Hashizume K, Iwata T (2002) Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation 74:543–550CrossRefPubMed
65.
Zurück zum Zitat Verolet CM, Posfay-Barbe KM (2015) Live virus vaccines in transplantation: friend or foe? Curr Infect Dis Rep 17:472CrossRefPubMed Verolet CM, Posfay-Barbe KM (2015) Live virus vaccines in transplantation: friend or foe? Curr Infect Dis Rep 17:472CrossRefPubMed
66.
Zurück zum Zitat Kawano Y, Suzuki M, Kawada J, Kimura H, Kamei H, Ohnishi Y, Ono Y, Uchida H, Ogura Y, Ito Y (2015) Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine 33:1440–1445CrossRefPubMed Kawano Y, Suzuki M, Kawada J, Kimura H, Kamei H, Ohnishi Y, Ono Y, Uchida H, Ogura Y, Ito Y (2015) Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine 33:1440–1445CrossRefPubMed
67.
Zurück zum Zitat Shinjoh M, Hoshino K, Takahashi T, Nakayama T (2015) Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 33:701–707CrossRefPubMed Shinjoh M, Hoshino K, Takahashi T, Nakayama T (2015) Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 33:701–707CrossRefPubMed
68.
69.
Zurück zum Zitat Buda K, Tubergen DG, Levin MJ (1996) The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 18:106–112CrossRefPubMed Buda K, Tubergen DG, Levin MJ (1996) The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 18:106–112CrossRefPubMed
70.
Zurück zum Zitat Kraft JN, Shaw JC (2006) Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol 142:943–945CrossRefPubMed Kraft JN, Shaw JC (2006) Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol 142:943–945CrossRefPubMed
71.
Zurück zum Zitat Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, Kochanowicz S, Seipel KR, Levin MJ (2006) Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 6:565–568CrossRefPubMed Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, Kochanowicz S, Seipel KR, Levin MJ (2006) Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 6:565–568CrossRefPubMed
72.
Zurück zum Zitat Posfay-Barbe KM, Pittet LF, Sottas C, Grillet S, Wildhaber BE, Rodriguez M, Kaiser L, Belli DC, McLin VA, Siegrist CA (2012) Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am J Transplant 12:2974–2985CrossRefPubMed Posfay-Barbe KM, Pittet LF, Sottas C, Grillet S, Wildhaber BE, Rodriguez M, Kaiser L, Belli DC, McLin VA, Siegrist CA (2012) Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am J Transplant 12:2974–2985CrossRefPubMed
73.
Zurück zum Zitat Hall V, Banerjee E, Kenyon C, Strain A, Griffith J, Como-Sabetti K, Heath J, Bahta L, Martin K, McMahon M, Johnson D, Roddy M, Dunn D, Ehresmann K (2017) Measles outbreak—Minnesota April-May 2017. MMWR Morb Mortal Wkly Rep 66:713–717CrossRefPubMedPubMedCentral Hall V, Banerjee E, Kenyon C, Strain A, Griffith J, Como-Sabetti K, Heath J, Bahta L, Martin K, McMahon M, Johnson D, Roddy M, Dunn D, Ehresmann K (2017) Measles outbreak—Minnesota April-May 2017. MMWR Morb Mortal Wkly Rep 66:713–717CrossRefPubMedPubMedCentral
74.
Zurück zum Zitat Sternfeld T, Spori-Byrtus V, Riediger C, Langer R, Friess H, Schmid RM, Schulte-Frohlinde E (2010) Acute measles infection triggering an episode of liver transplant rejection. Int J Infect Dis 14:e528–e530CrossRefPubMed Sternfeld T, Spori-Byrtus V, Riediger C, Langer R, Friess H, Schmid RM, Schulte-Frohlinde E (2010) Acute measles infection triggering an episode of liver transplant rejection. Int J Infect Dis 14:e528–e530CrossRefPubMed
75.
Zurück zum Zitat Kidd IM, Booth CJ, Rigden SP, Tong CY, MacMahon EM (2003) Measles-associated encephalitis in children with renal transplants: a predictable effect of waning herd immunity? Lancet 362:832CrossRefPubMed Kidd IM, Booth CJ, Rigden SP, Tong CY, MacMahon EM (2003) Measles-associated encephalitis in children with renal transplants: a predictable effect of waning herd immunity? Lancet 362:832CrossRefPubMed
76.
Zurück zum Zitat Baas MC, van Donselaar KA, Florquin S, van Binnendijk RS, ten Berge IJ, Bemelman FJ (2009) Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant 9:2186–2189CrossRefPubMed Baas MC, van Donselaar KA, Florquin S, van Binnendijk RS, ten Berge IJ, Bemelman FJ (2009) Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant 9:2186–2189CrossRefPubMed
77.
Zurück zum Zitat Rand EB, McCarthy CA, Whitington PF (1993) Measles vaccination after orthotopic liver transplantation. J Pediatr 123:87–89CrossRefPubMed Rand EB, McCarthy CA, Whitington PF (1993) Measles vaccination after orthotopic liver transplantation. J Pediatr 123:87–89CrossRefPubMed
78.
Zurück zum Zitat Cortese MM, Parashar UD (2009) Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 58:1–25PubMed Cortese MM, Parashar UD (2009) Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 58:1–25PubMed
80.
Zurück zum Zitat Uslan DZ, Patel R, Virk A (2008) International travel and exposure risks in solid-organ transplant recipients. Transplantation 86:407–412CrossRefPubMed Uslan DZ, Patel R, Virk A (2008) International travel and exposure risks in solid-organ transplant recipients. Transplantation 86:407–412CrossRefPubMed
81.
Zurück zum Zitat Keystone JS, Freedman DO, Kozarsky PE, Connor BA, Nothdurft HD (2013) Travel Medicine. Elsevier, Third Edition Keystone JS, Freedman DO, Kozarsky PE, Connor BA, Nothdurft HD (2013) Travel Medicine. Elsevier, Third Edition
82.
Zurück zum Zitat Stark K, Gunther M, Neuhaus R, Reinke P, Schroder K, Linnig S, Bienzle U (1999) Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180:2014–2017CrossRefPubMed Stark K, Gunther M, Neuhaus R, Reinke P, Schroder K, Linnig S, Bienzle U (1999) Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180:2014–2017CrossRefPubMed
83.
Zurück zum Zitat Garcia Garrido HM, Wieten RW, Grobusch MP, Goorhuis A (2015) Response to hepatitis A vaccination in immunocompromised travelers. J Infect Dis 212:378–385CrossRefPubMed Garcia Garrido HM, Wieten RW, Grobusch MP, Goorhuis A (2015) Response to hepatitis A vaccination in immunocompromised travelers. J Infect Dis 212:378–385CrossRefPubMed
84.
Zurück zum Zitat Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U (2001) Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71:477–479CrossRefPubMed Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U (2001) Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71:477–479CrossRefPubMed
85.
Zurück zum Zitat Huzly D, Neifer S, Reinke P, Schroder K, Schonfeld C, Hofmann T, Bienzle U (1997) Routine immunizations in adult renal transplant recipients. Transplantation 63:839–845CrossRefPubMed Huzly D, Neifer S, Reinke P, Schroder K, Schonfeld C, Hofmann T, Bienzle U (1997) Routine immunizations in adult renal transplant recipients. Transplantation 63:839–845CrossRefPubMed
86.
Zurück zum Zitat Myers AL, Christenson JC (2015) Approach to immunization for the traveling child. Infect Dis Clin N Am 29:745–757CrossRef Myers AL, Christenson JC (2015) Approach to immunization for the traveling child. Infect Dis Clin N Am 29:745–757CrossRef
Metadaten
Titel
Vaccinations in pediatric kidney transplant recipients
Publikationsdatum
18.04.2018
Erschienen in
Pediatric Nephrology / Ausgabe 4/2019
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-3953-z

Weitere Artikel der Ausgabe 4/2019

Pediatric Nephrology 4/2019 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.